Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

NPS and SmithKline Beecham extend osteoporosis agreement

Nov. 5, 1997

Labeling changes for Rezulin; FDA and manufacturer recommend liver function tests

Nov. 5, 1997

Novo Nordisk reports improved human insulin derivatives

Nov. 5, 1997

Phase III safety and efficacy data reported for one-alpha D2

Nov. 4, 1997

Preclinical results with Ergo Science's neuroendocrine resetting therapy

Nov. 4, 1997

Sequana and Glaxo Wellcome revise diabetes/obesity alliance

Nov. 4, 1997

Pamidronate for preventing glucocorticoid-induced osteoporosis

Nov. 3, 1997

New neurotransmitter implicated in hunger and satiety

Oct. 31, 1997

Antiprogestational agents available from the NIH

Oct. 31, 1997

NIAID researchers report advances in gene therapy for CGD

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...